LOS ANGELES, Aug. 17, 2023 /PRNewswire/ -- P.E. Barrington, the internationally acclaimed award-winning author announces his Amazon #1 Bestseller "Who Okayed This?! The Riveting Life of Grant Davis" ...
The FDA has approved selumetinib (Koselugo, AstraZeneca) for adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). Selumetinib, an oral kinase ...
The United States Food and Drug Administration (FDA) has approved Spravato (esketamine), a nasal spray from Johnson & Johnson, as a stand-alone therapy for adults with major depressive disorder (MDD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results